Category Archives: Investment

Medical Stock Spotlight: Three winners from last week hit with profit-taking, while one big loser rebounds. This week, Provention shines, but Cymabay bombs.

Stocks continue to be whipsawed by sudden upward, then plunging, prices, only to reverse direction again as political and economic uncertainty reigns supreme. Here are four prime examples of this… Read more »

Healthcare stocks rattled by Trump’s threat to force public pricing disclosure across the entire sector. The top winners, losers, and reasons why.

President Trump is expected to sign an executive order this week that would require for the first time disclosure of prices across the healthcare industry, in a move that officials… Read more »

Medical stocks resemble Mr. Toad’s Wild Ride with brave investors tightening their seat belts and neck braces for more uncertainty, price fluctuation.

Health-sector stocks were whipsawed upward, downward, backward and forward last week, rekindling memories of the Yardbirds’ hit song in the 60’s with a similar name. Still, when the dust settled,… Read more »

Seven health-sector IPOs do the limbo and raise $499M, seconds before market falls off a cliff.

Trade war fears are crushing stocks, and the their swan dive onto the rocks could keep going if Presidents Trump and China’s Xi Jinping keep tossing tariff grenades at each… Read more »

Healthcare IPOs still on a tear as pricings and registrations keep Wall Street, SEC on their toes.

Despite President Trump’s threatening trade Tweets to China and the resulting drag on stocks, only the health sector came out ahead on Monday (May 6, 2019), and the IPO action… Read more »

Healthcare stocks continue rise from the ashes as legislative uncertainties wane; sanity, fundamentals return.

Several Democratic presidential candidates have embraced “Medicare for all” as a rallying cry. Others are calling for a variety of healthcare reforms, such as lowering Medicare’s eligibility age from the… Read more »

Health-sector IPO action defies market jitters as Q1 earnings, the Federal Reserve and China trade talks take front stage.

Undaunted by the crushing weight of uncertainty affecting healthcare stock prices lately, the IPO action in New York continues to race ahead as though determined to prove Hong Kong’s budding… Read more »